VACCINEX INC (VCNX:OTCMKTS)
$1.05 0.05 (5%)
Analysed VACCINEX INC (VCNX:OTCMKTS) News Sources
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease
23-12-2025
yahoo.com
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting
27-05-2025
yahoo.com
What is the current price of VACCINEX INC (VCNX:OTCMKTS)?
The current price of VACCINEX INC (VCNX:OTCMKTS) is $1.05.
VACCINEX INC (VCNX:OTCMKTS) absolute price change since previous trading day?
The absolute price change of VACCINEX INC (VCNX:OTCMKTS) since the previous trading day is $0.05.
VACCINEX INC (VCNX:OTCMKTS) percentage price change since previous trading day?
The percentage price change of VACCINEX INC (VCNX:OTCMKTS) since the previous trading day is 5%.
What is the most recent average sentiment score for VACCINEX INC (VCNX:OTCMKTS)?
The most recent average sentiment score for VACCINEX INC (VCNX:OTCMKTS) is 87 out of 100.
What is the most recent average sentiment for VACCINEX INC (VCNX:OTCMKTS)?
The most recent sentiment for VACCINEX INC (VCNX:OTCMKTS) is .
SEC-8K** Filing Available For VACCINEX INC (VCNX:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.